|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Current assets | |||||||||||||||||||
| HST receivable | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Prepaid expense | |||||||||||||||||||
| Goods and services tax receivable | |||||||||||||||||||
| Accounts receivable | |||||||||||||||||||
| Inventory | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Non-current assets | |||||||||||||||||||
| Equipment, net | |||||||||||||||||||
| Right-of-use building, net | |||||||||||||||||||
| Investments | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | |||||||||||||||||||
| Current liabilities | |||||||||||||||||||
| Bank overdraft | |||||||||||||||||||
| Accrued legal settlement | |||||||||||||||||||
| Deferred revenue | |||||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||||
| Accrued interest | |||||||||||||||||||
| Notes payable | |||||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||||
| Accrued interest | |||||||||||||||||||
| Deferred revenue | |||||||||||||||||||
| Notes payable | |||||||||||||||||||
| Convertible notes | |||||||||||||||||||
| Derivative conversion feature | |||||||||||||||||||
| Loan payable - related party | |||||||||||||||||||
| Loans payable to related parties | |||||||||||||||||||
| Loans payable to related parties, current portion | |||||||||||||||||||
| Royalty payable | |||||||||||||||||||
| Liability for right-of-use building, current portion | |||||||||||||||||||
| Obligation to issue shares | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Non-current liability | |||||||||||||||||||
| Loans payable to related parties | |||||||||||||||||||
| Liability for right-of-use building | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Preferred stock value | |||||||||||||||||||
| Series A Preferred Stock | |||||||||||||||||||
| Series B Preferred Stock | |||||||||||||||||||
| Series C Preferred Stock | |||||||||||||||||||
| Series B, Preferred Stock | |||||||||||||||||||
| Total preferred stock value | |||||||||||||||||||
| Common shares, $0.0001 par value; 5,000,000,000 and 5,000,000,000 shares authorized, 708,689,905 and 662,501,405 issued and outstanding as at June 30, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Treasury stock, $0.0001 par value 6,230,761 shares as at June 30, 2024 and December 31, 2023 | |||||||||||||||||||
| Treasury Stock, Common, Value | |||||||||||||||||||
| Treasury shares, $0.0001 par value 6,230,761 shares as at September 30, 2025 and December 31, 2024 | |||||||||||||||||||
| Treasury shares, $0.0001 par value 6,230,761 shares as at March 31, 2026 and December 31, 2025 | |||||||||||||||||||
| Shares to be issued | |||||||||||||||||||
| Treasury shares, $0.0001 par value 6,230,761 shares as at June 30, 2026 and December 31, 2025 | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||||||||
| Total shareholders’ deficit | |||||||||||||||||||
| Total liabilities and shareholders’ deficit | |||||||||||||||||||
Loading...
